Methods and compositions for controlling translation of HCV proteins
View Patent ↗Embodiments of the present invention feature methods and compositions for controlling the translation of viral peptides and proteins from viral nucleic acid, with particular applications to pestivirus and HCV. The methods and compositions feature control elements of the 5′UT region of the viral genome.
1. A method of controlling translation of hepatitis C virus (HCV) proteins from HCV nucleic acid comprising the steps:
providing a non-naturally occurring first nucleic acid which first nucleic acid comprises a sequence having ten or more nucleotides complementary to a sense strand within the 5′ UT region of HCV nucleic acid, wherein said first nucleic acid hybridizes to bases 1–23 of (SEQ ID NO: 1); and
contacting said HCV nucleic acid with said first nucleic acid under conditions where said first nucleic acid and HCV nucleic acid form a hybridization product, whereby translation of the HCV nucleic acid is altered.
2. A method of controlling translation of hepatitis C virus (HCV) proteins from HCV nucleic acid comprising the steps:
providing a non-naturally occurring first nucleic acid which first nucleic acid comprises a sequence having ten or more nucleotides complementary to a sense strand within the 5′ UT region of HCV nucleic acid, wherein said first nucleic acid hybridizes to bases 277–300 of (SEQ ID NO: 1); and
contacting said HCV nucleic acid with said first nucleic acid under conditions where said first nucleic acid and HCV nucleic acid form a hybridization product, whereby translation of the HCV nucleic acid is altered.
3. The method of claim 2 wherein said first nucleic acid is a phosphorothioate nucleic acid analog.
4. A method of controlling the translation of hepatitis C virus (HCV) proteins from HCV nucleic acid comprising the steps:
providing a non-naturally occurring first nucleic acid which first nucleic acid comprises a sequence having ten or more nucleotides complementary to a sense strand within the 5′UT region of HCV nucleic acid, wherein said first nucleic acid comprises a sequence selected from the group consisting of a hairpin-forming region, a pestivirus homology box IV area, and a cleavage area at which the full length HCV RNA is cleaved to form a subgenomic HCV RNA;
contacting said HCV nucleic acid with said first nucleic acid under conditions where said first nucleic acid and HCV nucleic acid form a hybridization product, whereby translation of the HCV nucleic acid is altered; and transcribing a non-naturally occurring second nucleic acid comprising a promoter operatively linked to a sequence complementary to said first nucleic acid.
5. The method of claim 4 wherein said second nucleic acid and promoter are placed in a cell infected with HCV, which cell transcribes said second nucleic acid.
6. The method of claim 3 wherein said first nucleic acid further comprises a cholesteryl moiety linked at the 3′ end.